HemaSphere (Oct 2022)

P111: Phase I Trial of Brentuximab Vedotin plus Cyclosporine in Relapsed/Refractory Hodgkin Lymphoma

  • Swetha Kambhampati,
  • Matthew Mei,
  • Lu Chen,
  • Sandrine Puvurel,
  • Robert Chen,
  • Leslie Popplewell,
  • Liana Nikolaenko,
  • Lacolle Peters,
  • Saro Armenian,
  • Larry Kwak,
  • Steven T. Rosen,
  • Stephen Forman,
  • Alex F. Herrera

DOI
https://doi.org/10.1097/01.HS9.0000891012.42031.20
Journal volume & issue
Vol. 6
pp. 52 – 52

Abstract

Read online

No abstracts available.